Cleveland Clinic Neurological Institute Explores Precision Medicine in Multiple Sclerosis Treatment
NeurologyLive has partnered with the Cleveland Clinic Neurological Institute to launch a new Roundtable series titled 'Precision Medicine in Multiple Sclerosis: Advances & Unanswered Questions.' This series aims to delve into the current state of precision medicine within the field of multiple sclerosis (MS). The discussions feature experts from the Cleveland Clinic's Mellen Center for Multiple Sclerosis Treatment and Research, including Robert Bermel, MD, director; Marisa McGinley, DO, staff neurologist; and Rebecca Cebull, CNP, certified nurse practitioner. The panel will address various aspects of MS, such as biomarkers, advanced imaging techniques, genetics, progression independent of relapse activity, and the existing gaps between the theoretical promise of individualized care and its practical application in daily clinical practice. While precision medicine is a widely used term in MS, its practical definition remains largely unsettled. Unlike fields like oncology and rheumatology, which have long cu...